Atlas Trials

CMV pp65 Specific T Cell Adoptive Immunotherapy in Allogeneic Stem Cell Transplantation for Malignant Disease

Clinical trial NCT00611637 · TERMINATED

Trial details

NCT number
NCT00611637
Sponsor
H. Kim Lyerly
Status
TERMINATED
Phase
Phase 1
Study type
INTERVENTIONAL
Allogeneic Stem Cell Transplantation
Start date
2005-08-01
Primary completion
2008-02-01
Enrollment
2

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.